Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: Studies in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 75, Issue 5, 1992, Pages 1220-1225

  Rabinovicit, Jaron ^a,c   Rothman, Paula ^a   Monroe, Scott E ^a,b   Nerenberg, Clinton ^a,b   Jaffe, Robert B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GANIRELIX; HISTAMINE; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; THYROTROPIN;

ADULT; AGED; ALPHA CHAIN; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENDOCRINE SYSTEM; FEMALE; FOLLITROPIN BLOOD LEVEL; HISTAMINE RELEASE; HORMONE INHIBITION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; OVULATION INHIBITION; POSTMENOPAUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTOSTERONE BLOOD LEVEL;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE GLANDS; FEMALE; GONADORELIN; GONADOTROPINS; HISTAMINE RELEASE; HUMAN; MENOPAUSE; MIDDLE AGE; PROLACTIN; SUPPORT, U.S. GOV'T, P.H.S.; TESTOSTERONE;

EID: 0026463874     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.75.5.1385467     Document Type: Article

References (26)

1. Matsuo H, Baba Y, Nair RM, Shally AV. 1971 Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun. 43:1334-1339.
2. 2-LRF. The synthesis, purification and characterization of two LRF analogues antagonistic to LRF. Biochem Biophys Res Commun. 47:551-556.
3. Cetel NS, Rivier J, Vale W, Yen SSC. 1983 The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin releasing hormone. J Clin Endocrinol Metab. 57:62-65.
4. Mais V, Kazer RR, Cetel NS, Rivier J, Vale W, Yen SSC. 1986 The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a GnRH antagonist as a probe. J Clin Endocrinol Metab. 62:1250-1255.
5. Davis MR, Veldhuis JD, Rogol AD, Dufau ML, Catt KJ. 1987 Sustained inhibitory actions of a potent antagonist of gonadotropin releasing hormone in postmenopausal women. J Clin Endocrinol Metab. 64:1268-1274.
6. Pavlou SN, Wakefield GB, Island DP, et al. 1987 Suppression of pituitary-gonadal function by a potent new luteinizing hormone antagonist in normal men. J Clin Endocrinol Metab. 64:931-936.
7. Hall JE, Brodie TD, Badger TM, et al. 1988 Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. J Clin Endocrinol Metab. 67:524-531.
8. Jockenhovel F, Bhasin S, Steiner BS, Rivier JE, Vale WW, Swerdloff RS. 1988 Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men. J Clin Endocrinol Metab. 66:1065-1070.
9. Kessel B, Dahl KD, Kazer RR, et al. 1988 The dependency of bioactive FSH on gonadotropin releasing hormone in hypogonadal and cycling women. J Clin Endocrinol Metab. 66:361-366.
10. Mortola JF, Sathanandan M, Pavlou S, et al. 1989 Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamie studies. Fertil Steril. 51:957-963.
11. Hall JE, Whitcomb RW, Rivier JE, Vale WW, Crowley WF. 1990 Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. J Clin Endocrinol Metab. 70:328-335.
12. Lahlou N, Delivet S, Bardin CW, Roger M, Spitz IM, Bouchard P. 1990 Changes in gonadotropin and a-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males. Fertil Steril. 53:898-905.
13. Marshall LA, Fluker MR, Jaffe RB, Monroe SE. 1991 Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (Detirelix). J Clin Endocrinol Metab. 72:927-933.
14. Nekola MV, Morgan JE, O'Neil CE, Hocart SJ, Coy DH. 1987 Use of the cutaneous anaphylactoid test to detect differences in mast cell mediator-releasing activity among LHRH peptides. Int Arch Allergy Appl Immunol. 84:316-320.
15. Morgan JE, O'Neill CE, Coy DH, Hocart SJ, Nekola MV. 1986 Antagonistic analogs of luteinizing hormone releasing hormone are mast cell secretagogues. Int Arch Allergy Appl Immunol. 80:70-75.
16. 3]GnRH. Life Sci. 37:506-514.
17. Monroe SE, Blumenfeld Z, Andreyko J, Schriock E, Henzl MR, Jaffe RB. 1986 Dose-dependent inhibition of pituitary-ovarian function during administration of a GnRH agonistic analog (nafarelin). J Clin Endocrinol Metab. 63:1334-1341.
18. Andreyko JL, Monroe SE, Marshall LA, Fluker MR, Nerenberg CA, Jaffe RB. 1992 Concordant suppression of serum immunoreactive LH, FSH, alpha subunit, bioactive LH and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (Detirelix). J Clin Endocrinol Metab. 74:399-405.
19. Whitcomb RW, Sangha JS, Schneyer AL, Crowley WF. 1988 Improved measurements of free alpha subunit of glycoprotein hormones by assay with use of a monoclonal antibody. Clin Chem. 34:2022-2025.
20. Abraham GE, Manlimos FS, Garza R. 1977 Radioimmunoassay of steroids. In: Abraham GE, ed. Handbook of Radioimmunoassay. New York: Marcel Dekker, pp 591-656.
21. Winters SJ, Troen P. 1988 α-Subunit secretion in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 66:338-342.
22. Kourides IA, Weintraub BD, Ridgway EC, Maloof F. 1975 Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab. 40:872-885.
23. Judd HL. 1976 Hormonal dynamics associated with the menopause. Clin Obstet Gynecol. 19:775-788.
24. Vermeulen A. 1976 The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 42:247-253.
25. Yen SSC, Hoff JD, Lasley BL, Casper RF, Sheehan K. 1980 Induction of prolactin release by LRF and LRF-agonist. Life Sci. 26:1963-1967.
26. Olive DL, Sabella V, Riehl RM, Schenken RS, Moreno A. 1989 Gonadotropin-releasing hormone antagonists attenuate estrogen/progesterone-induced hyperprolactinemia in monkeys. Fertil Steril. 51:1040-1045.